Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2012
10/02/2012CA2453676C Thermotherapy via targeted delivery of nanoscale magnetic particles
09/2012
09/27/2012WO2012129513A2 Blockage of pai-1 in diabetic cd34+ stem cells corrects cellular dysfunction
09/27/2012WO2012128582A2 A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
09/27/2012WO2012128461A2 Composition comprising black garlic and garcinia cambogia extracts for treating or preventing obesity or hyperlipidemia
09/27/2012WO2012127498A2 A novel herbal composition for the treatment of kidney stone and other urinary tract disorders
09/27/2012WO2012127431A1 Stabilized compositions of tetrahydrobiopterin
09/27/2012WO2012127037A2 A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
09/27/2012WO2012126901A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012WO2012126791A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/27/2012WO2012104263A3 1,4 oxazines as bace1 and/or bace2 inhibitors
09/27/2012WO2012097255A3 Therapeutic effect of heat shock proteins in preventing amylin aggregation in type 2 diabetes mellitus
09/27/2012WO2012078004A3 Composition comprising fermented tea extracts for reducing lipid level
09/27/2012US20120245213 Human type i taste receptor subunit 3 modulators and methods of using same
09/27/2012US20120245207 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
09/27/2012US20120245202 Methods and products for treating inflammation
09/27/2012US20120245200 Crystal form of quinoline compound and process for its production
09/27/2012US20120245195 Novel monohydrate of azaadamantane derivatives
09/27/2012US20120245194 Small molecule inhibitors of the alpha4-paxillin interaction
09/27/2012US20120245191 New azaspirodecanone compounds
09/27/2012US20120245172 Heterocyclic amine derivatives
09/27/2012US20120245169 Certain chemical entities, compositions and methods
09/27/2012US20120245148 Tetrahydroquinoxaline uera derivatives, their preparation and their therapeutic application
09/27/2012US20120245147 Inhibitors of thapsigargin-induced cell death
09/27/2012US20120245144 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245140 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245129 Use of s1p receptor modulator
09/27/2012US20120245122 Carotenoid-containing compositions and methods
09/27/2012US20120245110 Vascular leakage inhibitor
09/27/2012US20120245086 WNT10-Derived Peptide and Use Thereof
09/27/2012US20120245083 Derivatives of CGRP
09/27/2012US20120244236 Composition having lipolysis-promoting effect
09/27/2012US20120244229 Compositions and methods for nutrition supplementation
09/27/2012US20120244220 Atrovastatin-containing coated preparation
09/27/2012US20120244218 Calcium supplement
09/27/2012US20120244217 4-methylpyrazole formulations
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244207 Methods For Increasing Efficacy of Lipid Formulated siRNA
09/27/2012US20120244149 Benzoxazepin pi3k inhibitor compounds and methods of use
09/27/2012US20120244148 Anti-interferon-alpha antibodies
09/27/2012US20120244136 Cardiac-Specific Protein Targeting Domain
09/27/2012US20120244125 Bifidobacterium longum atcc baa-999 (bl999) and weight control
09/27/2012US20120244096 Plant extract, compositions containing same, method of extraction and uses thereof
09/27/2012US20120244069 Human monoclonal antibodies against cd25
09/27/2012US20120241356 Heat- and vibration-stable insulin preparations
09/27/2012CA2830540A1 Glucosylceramide synthase inhibitors
09/27/2012CA2830476A1 Compositions and methods useful for ameliorating age related maladies
09/27/2012CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012CA2822783A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/26/2012EP2502996A2 Anti-FGF23 antibody and pharmaceutical composition comprising the same
09/26/2012EP2502939A1 Nonnatural collagen-like protein and use thereof
09/26/2012EP2502909A1 Aminopyridine derivative
09/26/2012EP2501685A1 [1,5]-diazocin derivatives
09/26/2012EP2501383A2 Oral formulation for dexlansoprazole
09/26/2012CN102695708A N1-pyrazolospiroketone acetyl-coA carboxylase inhibitors
09/26/2012CN102695697A Novel multifunctional peptidase inhibitors, especially for medical use
09/26/2012CN102695521A Plant extract, compositons containing same, method of extraction and uses thereof
09/26/2012CN102695506A N-piperidinyl acetamide derivatives as calcium channel blockers
09/26/2012CN102690352A Fusion protein containing GLP-1, and pharmaceutical compositions and applications thereof
09/26/2012CN102690346A Polypeptide treating diabetes, its preparation method and application
09/26/2012CN102690324A Gynura bicolor protein extract, and preparation method and application thereof
09/26/2012CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors
09/26/2012CN102690259A Compound with function of diuresis, preparation method and functions thereof
09/26/2012CN102690221A 改性的拟赖氨酸化合物 Proposed modification of lysine compound
09/26/2012CN102688497A Preparation method of polypeptide zinc-ferrum supplementary
09/26/2012CN102688482A Injectable sustained-release preparation of polypeptide drug for treating diabetes and production method thereof
09/26/2012CN102688481A Injection for nourishing myocardium
09/26/2012CN102688480A Sustained-release preparation of polypeptide drug for treating diabetes and production method thereof
09/26/2012CN102688445A Traditional Chinese medicine for treating diabetes and preparation method thereof
09/26/2012CN102688442A Drug for treating obesity
09/26/2012CN102688440A Medicament for reducing weight, expelling toxicity and beautifying and preparation method thereof
09/26/2012CN102688434A Traditional Chinese medicine (TCM) for treating diabetes
09/26/2012CN102688397A Application of Awei capsules to preparation of drugs for treating hyperlipemia and fatty liver disease
09/26/2012CN102688366A Medicine for treating senile adiposity
09/26/2012CN102688324A Traditional Chinese medicine composition with functions of reducing fat and losing weight
09/26/2012CN102688296A Chinese medicine composition with effect of reducing blood fat as well as preparation method and application thereof
09/26/2012CN102688295A Chinese medicine composition for controlling metabolic diseases as well as preparation method and application thereof
09/26/2012CN102688252A Acarbose oral solid preparation composition and preparation method thereof
09/26/2012CN102688235A Lercanidipine hydrochloride composite tablet, preparation method thereof and application as antihypertensive drug
09/26/2012CN102688215A Isradipine controlled-release tablet and preparation method and application thereof
09/26/2012CN102688211A Levocarnitine osmotic pump slow and controlled-release tablet and preparation method thereof
09/26/2012CN102688206A Pitavastatin calcium tablet and preparation method thereof
09/26/2012CN102688201A Vitamin B6 and lyophiled powder composition used for injection, and preparation method thereof
09/26/2012CN102688192A Sustained-release preparation of polypeptide drug for treating diabetes and production method thereof
09/26/2012CN102688187A Fructose medicament composition injection and preparation method thereof
09/26/2012CN102687890A Plant beverage with effect of reducing blood sugar, and preparation method and application thereof
09/26/2012CN102351776B Fluvastatin sodium compound and preparation method thereof
09/26/2012CN102274396B Traditional Chinese medicine for treating diabetic nephropathy and preparation method thereof
09/26/2012CN102266325B Melbine crystal and medicinal composition of melbine and saxagliptin and preparation method thereof
09/26/2012CN102228515B Separation and enrichment method of total flavones and total alkaloids of Lotus Plumule
09/26/2012CN102228452B Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof
09/26/2012CN102204602B Lipid-lowering and antihypertensive health tea and preparation method thereof
09/26/2012CN102204601B Blood sugar-reducing health-care tea and preparation method thereof
09/26/2012CN102144968B Oral suspension of liposome-encapsulated insulin lyophilized preparation and preparation process thereof
09/26/2012CN102140126B Rotundic acid derivative and synthesis method thereof as well as application of rotundic acid derivative in preparing medicament for preventing and curing cardiovascular disease
09/26/2012CN101987179B Red yeast rice generated component composite capable of resisting body fat formation and preparation method thereof
09/26/2012CN101926979B Use of fungal immunomodulatory protein
09/26/2012CN101912617B Application of MG53 gene to treatment of insulin resistance, type II diabetes mellitus and related diseases thereof
09/26/2012CN101883571B Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin
09/26/2012CN101875700B Method for improving bioactivity of exendin fusion protein